• Blog
  • Home Infusion Therapy Market Growth Analysis | 2023-2028

    Home Infusion Therapy Market Growth Analysis | 2023-2028

    Home Infusion Therapy Market Growth Analysis | 2023-2028
    Report code - SRHL175 Delivery - 2 Weeks
    Home Infusion Therapy Market Size, Share, Trend, Forecast & Industry Analysis: 20 See more...

    Market Insights

    The Home Infusion Therapy Market is expected to grow from US$ 32.12 billion in 2022 to US$ 51.83 billion by 2028 at a healthy CAGR of 8.2% during the forecast period.

    Wish to get a free sample? Register Here

    What is Home Infusion Therapy?

    Home infusion therapy refers to the administration of intravenous medications, fluids, or nutrition to patients in the comfort of their own homes. It involves the use of specialized equipment and skilled healthcare professionals who deliver these treatments to individuals with chronic illnesses, infections, or other medical conditions that require ongoing intravenous therapy. Home infusion therapy offers numerous advantages, including increased convenience, reduced healthcare costs, improved patient satisfaction, and minimized risks of hospital-acquired infections. It allows patients to receive necessary treatments while maintaining their daily routines and enjoying a higher quality of life. Overall, home infusion therapy promotes accessible and personalized healthcare delivery in a familiar and supportive environment.

    Market Dynamics

    The home infusion therapy market is influenced by several factors. The surging incidences of chronic diseases have steered the demand for long-term intravenous treatments outside of conventional healthcare settings. The rising geriatric population and the preference for cost-effective healthcare solutions also contribute to market growth. Technological advancements, such as portable infusion pumps and remote monitoring systems, enhance the feasibility and safety of home-based treatments.

    Additionally, efforts undertaken by the government to promote home healthcare and the shift towards value-based care models further support market expansion. These factors create a favorable environment for growth and innovation in the home infusion therapy sector.

    Segments Analysis

    Home Infusion Therapy Market Report Overview

    Market Size in 2028

    USD 51.83 billion

    Market Size in 2022

    USD 32.12 billion

    Market Growth (2023-2028)

    CAGR of 8.2%

    Base Year of Study


    Trend Period


    Forecast Period


    Segments Covered

    By Product Type (Infusion Pump, Intravenous Sets, IV Cannulas, and Needleless Connectors)  

    By Application Type (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, & Others)

    By Region (North America, Europe, Asia-Pacific, and the Rest of the World)

    Dominant Region

    The North American market accounted for the largest market share.

    By Product Type

    Based on the product type, the market is segmented as infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pump segment is estimated to maintain its dominance over the forecast period, owing to properties such as the delivery of fluids at precise programmed rates.

    By Application Type

    Based on the application type, the market is segmented as anti-infective, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, and others. The anti-infective segment accounted for the largest share of the market and is expected to maintain its dominance during the forecast period. The growth of the segment can be attributed to growing demand from antibiotic and anti-fungal medicine administrations.

    Regional Analysis

    In terms of regions, North America is projected to be the largest market. The North American market is expected to grow with a lucrative CAGR over the forecast period owing to well-developed healthcare infrastructure, the presence of skilled medical professionals, high adoption of advanced technology, and high healthcare expenditure.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    Some of the major players in the home infusion therapy market are:

    • B Braun Melsungen AG
    • Baxter International, Inc.
    • Becton
    • Dickinson and Company
    • Eli Lilly and Company
    • Fresenius Kabi
    • ICU Medical Inc.
    • JMS Co., Ltd.
    • Smiths Medical.
    • Terumo Corporation
    • Cosmed.

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Home Infusion Therapy Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the product types by application type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and Needleless connectors, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Home Infusion Therapy Market is expected to grow at a healthy CAGR of 8.2% during the forecast period.

    B Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Eli Lilly and Company, Fresenius Kabi, ICU Medical Inc., JMS Co., Ltd., Smiths Medical., Terumo Corporation, and Cosmed are among the key players in the home infusion therapy market.

    The Home Infusion Therapy Market is expected to grow from US$ 32.12 billion in 2022 to US$ 51.83 billion by 2028.

    North America is expected to remain the largest home infusion therapy market in the coming years.

    The anti-infective segment is expected to remain the dominant application type in the home infusion therapy market during the next five years.